|Dr. Thomas Kelley
VP of Business Development & Partnerships, ICHOM, EMEA
Thomas Kelley leads ICHOM’s work across Europe, the Middle East, and Africa (EMEA). He also has global responsibility for ICHOM’s engagement with the life science industry. He is based in the London office. Prior to working at ICHOM he practiced as a physician at an Academic Medical Centre in the UK, Oxford University Hospitals (OUH). Whilst at the OUH he worked in many parts of the hospital including general adult medicine, trauma and orthopedics, general surgery, emergency medicine, and plastic surgery. He continues to serve as the National Advisor for the UK junior doctor academic training program, a position he has held since 2012. He received his MD from the University of Manchester and MBA from the University of Oxford.
|Prof. Charles Normand
Edward Kennedy Professor of Health Policy &
Management, University of Dublin, Trinity College
Charles Normand is Edward Kennedy Professor of Health Policy and Management at the University of Dublin, Trinity College. He was for thirteen years Professor of Health Economics at the London School of Hygiene & Tropical Medicine, and remains a visiting professor there. He has worked also at the universities in Belfast, York and Stirling. He was a civil servant in Northern Ireland for four years and has worked in hospital management, including a period as chairman of the board at Central Middlesex Hospital and is currently on the boards of St. James's Hospital and Trinity Health Ireland. His BA and DPhil are in economics. Much of his work is on the evaluation of treatments and services, with a particular interest on neonatal technologies, heart disease and the major cancers. His has also worked on finance and delivery of health services and health care human resources. He has a particular interest in the consequences of population ageing on health and social care. He has carried out advisory work and research on health care reform in the new democracies in Central and Eastern Europe and the former Soviet Union, in Bangladesh, Malawi, Tanzania and in South Africa. He has published widely on health economics and financing, is author of two guidebooks on health insurance and of a textbook on health economics. He is a former President of the Association of Schools of Public Health in the European Region and chairs the steering committee of the WHO European Observatory on Health Systems and Policy.
|Mr. John Swords
Head of Procurement, Health Business Services (HBS), HSE
John has in excess of 30 years experience in the Health Service Executive from a Finance and Procurement perspective. As Head of Procurement, John is responsible for the strategic operational development and management of all Procurement related activity with an annual spend of approx €3.5bn on products and services across the Health Service.
A pro-active and supportive procurement professional in engaging with the Small Medium Sized Enterprises which has led to HBS Procurement developing a Strategy for Engaging with SME’s which has received much positive publicity particularly in the area of Supplier Engagements.
John and his Team have been instrumental in the implementation of the ‘One Voice for Health’ Procurement strategy which resides with Health Business Services (HBS). This has been a key enabler in achieving cost reduction, increased efficiencies and the adoption of streamlined standardised Procurement processes to avoid duplication of effort. An emphasis is also been placed on compliance with both National and EU Procurement Directives.
John is responsible for implementing the Procurement Plan inclusive of Sourcing, Logistics and Systems which are key enablers in providing front line services to patients. Procurement Plan forms a key part of the HBS Strategy 2017 – 2019.
|Dr. Mairin Ryan
Director Health Technology Assessment and Deputy Chief Executive Officer HIQA
Máirín joined HIQA as Director of Health Technology Assessment (HTA) in September 2007. She was appointed Deputy Chief Executive in September 2014. Prior to this appointment, Máirín was the Chief 1 Pharmacist at the National Centre for Pharmacoeconomics. She is an Assistant Professor in Pharmacoeconomics at Trinity College.
She and her team are responsible for conducting assessments of health technologies including drugs, devices, diagnostics and public health programs. In addition, HIQA has recently been selected to provide the evidence synthesis to support the development of National Clinical Guidelines and National Clinical Audit.
Máirín is a member of the National Clinical Effectiveness Committee. She is currently chairing the Ministerial Reference Group on Medicinal Cannabis. She also serves as Chair of the European Network of HTA (EUnetHTA) Assembly.
|Dr. Anne Dee
Health Technology Assessment Group Lead and Specialist in Public Health Medicine, Department of Public Health
HTAG is headed up by Dr. Anne Dee, who is qualified as a Consultant in Public Health Medicine. Anne specialises in the area of Health Economics, and has experience of Markov modelling, cost of illness studies, budget impact analysis as well as acute hospital activity and costing projections.
During her career, Anne has worked in emergency medicine, general practice and volunteered in a leprosy hospital in Nepal. She has worked in Public Health Medicine since 2006, and took up a specialist post in Limerick in 2010.
|Mr. Alan Brace
Director of Finance - Health and Social Services Group -
Alan was born in the Rhondda Valley and brought up in Tonyrefail. He now lives in Coity with his wife and three children.
He joined the NHS as a National Finance Management Trainee in 1984 and apart from two years in Local Government has spent his entire career in NHS Wales. Alan has been a Finance Director in a number of NHS Trusts in NHS Wales since 1994. In 2003 he took the opportunity offered by the creation of Local Health Boards in Wales to become Chief Executive of Carmarthenshire Local Health Board and remained there until 2008 when he returned to finance as Interim Director of Finance in Gwent NHS Trust.
From 2009 he was Director of Finance and Procurement and Deputy Chief Executive of Aneurin Bevan University Health Board and during 2012 Alan covered the post of Director of Finance for the Department of Health and Social care in Welsh Government and in September 2016 Alan took up this post permanently.
A former Chairman of the HFMA in Wales, Alan has also sat on the C.I.P.F.A Executive for Wales and their Welsh Advisory Group and represented Health on the National Finance Leadership Steering Group. Alan also takes a keen interest in finance staff development and developing the finance function within the NHS. In 2014 Alan was warded the HFMA Finance Director of the Year award.
During 2013 he established the Finance Leadership Academy for NHS Wales which he currently chairs. The aim of the Academy is develop a finance function in Wales that is best suited to Wales but comparable with the best anywhere. It aims to provide leadership and resources to promote research into finance and effective financial management, to ensure the talent pipeline in Wales is effectively managed and to learn from and adopt best practice wherever it exists.
Alan has also benefited from extended study leave to both Harvard Business School where he has studied both General Management and Leadership as well as Value measurement in Health Care and also Stanford Business School in California studying Not for Profit Leadership.
|Mr. Ameer Ally
Senior Market Access Manager, Edwards Lifesciences UKI
Ameer Ally is the Senior Market Access Manager for Edwards Lifesciences UK & Ireland. He has 35 years of experience in the healthcare sector. Ameer is an expert in the in the market access areas of regulatory affairs, government affairs, healthcare economics and reimbursement. He has broad product and geographic experience across both the pharmaceutical and medical technology industries. Ameer has been an active worker in the UK medical technology trade associations: ABHI, BHTA and SDMA and Europe in Eucomed.
|Mr. Kevin Bellinger
UniHA - Union des Hôpitaux pour les Achats
Kévin BELLENGER, biomedical engineer. Kevin is working as a purchaser specialized in biomedical engineering in a national purchasing central : GCS UniHA. He purchases all kind of biomedical equipments for french public hospitals (150-200 million euros annually), doing call for tenders in command group with other hospitals or directly in purchasing central. Kevin organizes and animates clinical and technique expert groups with adherents hospitals.
|Mr. Yves Verboven
Director Market Access & Economic Policies, Medtech Europe
Following a period of Clinical Engineering, Director clinical outcomes and research at Intermedics and Medtronic working in the field of Cardiac Rhythm Management and Heart Failure Management, Yves used to work for Alcon as Assistant Director Health Economics responsible for eye care Pharmaceutical as well as medical devices products. During these 20 years first in human testing was performed and clinical and health economic proof was developed to demonstrate the value of multiple health technologies. Yves holds a Master in Electro-Mechanical Engineer from the Catholic University of Leuven, a post-graduate in Business Administration and multiple patents and publications.